NVO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Novo Nordisk A/S to Contact the Firm Today!
NEW YORK, NY / ACCESS Newswire / March 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
NVO Stockholders Have Opportunity to Lead Novo Nordisk A/S Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Yahoo Finance13d
Novo’s Wegovy successor disappoints in second large trial
Novo Nordisk’s experimental drug CagriSema helped people who are overweight or obese and have diabetes lose about 14% of ...
NBC DFW13d
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Shares of Novo Nordisk fell on Monday, after the Danish pharmaceutical giant said its next-generation weight-loss drug CagriSema helped obese or overweight adult patients with type 2 diabetes drop ...